1 / 24

Routine Health Screenings: What you Should Know (A Gynecologist’s perspective)

Routine Health Screenings: What you Should Know (A Gynecologist’s perspective). Palm Beach State College Lunch and Learn Lecture Series September 18, 2012 Dudley Brown, Jr., MD, MBA. Background:. BS in Psychology--University of Miami (Coral Gables)

emily
Télécharger la présentation

Routine Health Screenings: What you Should Know (A Gynecologist’s perspective)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Routine Health Screenings: What you Should Know (A Gynecologist’s perspective) Palm Beach State College Lunch and Learn Lecture Series September 18, 2012 Dudley Brown, Jr., MD, MBA

  2. Background: • BS in Psychology--University of Miami (Coral Gables) • MD--University of Florida College of Medicine • Residency in Obstetrics and Gynecology--Cook County Hospital, Chicago, IL (Chief Resident) • Private Practice in Woodstock, IL for 8 yrs (Medical Director) • MBA--Northern Illinois University • Office locations: Forest Hill & N. Flagler Dr (by Good Samaritan Hospital) in WPB; University Dr in Jupiter • Surgeries and Deliveries at Good Samaritan and St Mary’s Medical Centers in WPB • (561)357-6277 • www.tenetfloridaphysicianservices.com

  3. Routine Health Screenings: Cancer Screening • Cervix • Breast • Ovary • Colorectal • Prostate

  4. Cervix: Worldwide • 2nd most common cancer in women • ~500,000 new cases/ year • ~275,000 deaths / year

  5. Cervix: Impact in the US • >70% decline in mortality last 60 years • #13 in cancer deaths for women • In 2010, ~12,200 new cases and ~4,200 deaths

  6. Cancer screening: Cervix • 50% of new cases are in unscreened women • 10% had not had a screen in 5 years • 30% due to system error (sampling, interpretation)

  7. Cervix: Current Pap Smear Recommendations • Under 21 y/o, do not screen • 21-29 y/o, Pap every 2 yrs • 30 y/o and older, Pap every 3 yrs if 3 consecutive negative tests • 65 y/o and older, stop if 3 consecutive negative tests & no abnormal tests in last 10yrs • Any age after hysterectomy, stop if done for benign condition (e.g. fibroids, abnormal periods) and no h/o HG CIN

  8. Cancer Screening: Breast (US Impact) • Most common cancer in women • #2 in cancer deaths in women • 37% decline in mortality from 1997 to 2005 • 2010 estimates; ~207,000 new cases, ~40,000 deaths

  9. Breast: Current Screening recommendations • Ages 40-49, every 1-2 yrs (varies by organization) • Ages 50-74, every 1-2 yrs (varies by organization) • Age 75 and older, No recommendation for age to stop • ACOG recommends clinical breast exam annually after 19 y/o • “Self breast awareness” recommended

  10. Cancer Screening: Ovary (US Impact) • 2nd most common Gyn Cancer • #1 in Gyn cancer deaths • 2010 estimates; ~21,800 new cases, ~13,800 deaths

  11. Cancer Screening: Ovary • ~75% diagnosed at > stage 2 • Nonspecific symptoms • No proven screening test • Recommended screening test is an annual pelvic exam • CA 125 is not a recommended screening test

  12. Ovary: CA 125 Liabilities • High false positive rate leading to unnecessary surgery and increased cost • Identifies late stage disease • Research continues for an effective screening test

  13. Cancer Screening: Colorectal • #3 in cancer deaths in women & men (#2 for Hispanic men) • 50% screening rate in US • Average risk people should begin screening at 50 y/o • Screening tests include; FOBT, Stool DNA test, Flexible Sigmoidoscopy, Colonoscopy

  14. Cancer Screening: Prostate • Most common cancer in men • Walnut-sized organ just below bladder and in front of rectum • 200,000 men diagnosed annually and 25,000 deaths • Risks factors: age > 50, African American, 1st degree relative with disease

  15. Cancer Screening: Prostate • Difficulty in starting urination • Weak or interrupted flow of urine • Frequent urination, especially at night • Difficulty in emptying the bladder completely • Pain or burning during urination • Blood in the urine or semen • Pain in the back, hips, or pelvis that doesn't go away • Painful ejaculation • Some men do not have any symptoms

  16. Cancer Screening: Prostate • Controversy exits regarding screening recommendations • USPSTF recommends against PSA-based screening in men without symptoms • Usual screening tests: Digital Rectal Exam (DRE) and Prostate Specific Antigen (PSA)

  17. Routine Health Screening: Benign Conditions • Thyroid • Diabetes • Cholesterol • Bone Density

  18. Routine Health Screening: Thyroid • Recommendations vary per organization • Start at 35 y/o and screen every 5 yrs with TSH blood test (American Thyroid Association) • Screen at 50 y/o (American College of Physicians) • Other organizations say only screen if someone in symptomatic • Bottom line, discuss with your physician, especially if there is a family history of Thyroid disease

  19. Routine Health Screening: Diabetes • Screen with blood test if BMI >25 and another risk factor present (e.g. Hypertension, age > 45, certain ethnic groups, habitual physical inactivity) American Diabetes Association • Screen if BP consistently > 153/80 (treated or untreated) USPSTF • Screen in pregnancy • Bottom line, discuss with your physician, especially if there is a family history of Diabetes

  20. Routine Health Screening: Osteoporosis • Osteoporosis is characterized by low bone mass (density) and architectural changes in the bone which increases the susceptibility to fracture

  21. Routine Health Screening: Bone Density • Postmenopausal women age 65 and older • Postmenopausal women younger than age 65 if risk factors are present (e.g. previous fracture as an adult, parents with h/o hip fracture, steroid therapy, low body weight, smoking) • No screening for premenopausal women

  22. Routine Health Screening: Cholesterol • Start screening with a blood test at age 20 and every 5 yrs after that, NCEP III • Start at age 20 for men or women risk factors for CHD, USPSTF • Start at age 35 for men and age 45 for women if no risk factors for CHD, USPSTF • Bottom line, speak with your doctor

  23. Summary: Prevention and Routine Screening • Lung (#2) • Colorectal (#3) • Diabetes • Cholesterol Lifestyle changes (proper diet, regular exercise, no smoking, alcohol in moderation)

  24. Questions? • Dr. Dudley Brown, Jr. • Board Certified, Ob/ Gyn • Offices in West Palm Beach and Jupiter • (561)357-6277 • Accepting New Patients

More Related